The healthcare sector is trading significantly higher, driven by strong quarterly earnings reports from sector heavyweights Merck (MRK) and Eli Lilly (LLY). [5, 9] Both pharmaceutical giants reported results that beat analyst expectations and raised their full-year forecasts, signaling robust demand and profitability. [5, 9] Eli Lilly's shares jumped after its blockbuster weight-loss drug, Zepbound, showed soaring sales, leading the company to raise its outlook for the third time this year. [9] Merck also saw its shares rise after topping estimates and boosting its profit outlook. [5]